Rhenman & Partners Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.52M | Hold |
|
|||||
|
2019
Q4 | $4.96M | Sell |
|
|||||
|
2019
Q3 | $3.16M | Buy |
|
|||||
|
2019
Q2 | $2.99M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.25M | Sell |
|
|||||
|
2017
Q3 | $2.32M | Buy |
|
|||||
|
2017
Q2 | $364K | Sell |
|
|||||
|
2017
Q1 | $3.39M | Buy |
|
|||||
|
2016
Q4 | $2.17M | Buy |
|
|||||
|
2016
Q3 | $1.65M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3.88M | Sell |
|
|||||
|
2015
Q3 | $5.31M | Buy |
|
|||||
|
2015
Q2 | $5.79M | Buy |
|
|||||
|
2015
Q1 | $6.49M | Buy |
|
|||||
|
2014
Q4 | $3.43M | Buy |
|
|||||
|
2014
Q3 | $4.4M | Buy |
|